ELIQUIS SPRINKLE
NDC 0003-0898, apixaban, capsule, from E.R. Squibb & Sons, L.L.C..
- Product NDC
- 0003-0898
- Status
- Listed
- Labeler
- E.R. Squibb & Sons, L.L.C.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA220073
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0003-0898 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- APIXABAN.15 mg/1
Pharmacologic classes
Factor Xa Inhibitor [EPC]; Factor Xa Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0003-0898-28 | 00003089828 | 28 CAPSULE in 1 BOTTLE (0003-0898-28) |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 0003-0898 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0003-0898 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0003-0898. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.